Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Sandoz Limited, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom
Azathioprine 25 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. White to yellowish-white film-coated tablet, biconvex, no score-line. |
One film-coated tablet contains 25 mg azathioprine.
Excipient(s) with known effect: Lactose
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Azathioprine |
Azathioprine is a pro-drug of 6-mercaptopurine (6-MP). 6-MP is inactive but acts as a purine antagonist and requires cellular uptake and intracellular anabolism to thioguanine nucleotides (TGNs) for immunosuppression. The TGNs and other metabolites (e.g. 6-methyl-mecaptopurine ribonucleotides) inhibit de novo purine synthesis and purine nucleotide interconversions. |
| List of Excipients |
|---|
|
Core: Lactose monohydrate Coating: Hypromellose Colouring agent: titanium dioxide (E171) |
The film-coated tablets are packed in either polypropylene-aluminium blister or PVC/PVDC-aluminium blister in a carton box.
The pack contains 20, 28, 30, 50, 90 or 100 film-coated tablets.
Not all pack sizes may be marketed.
Sandoz Limited, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom
PL 04416/1247
25/10/2002
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
